SETBP1 and chronic myelomonocytic leukemia: Somatic mutations of SETBP1 resulted in gain-of-function were associated with poor prognosis and myeloid leukemic transformation in patients with myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) [4, 29].